Clinical trials
Phase 2 Marijuana Abuse trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
69 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2004 | 8 |
| 2005 | 6 |
| 2006 | 3 |
| 2008 | 3 |
| 2009 | 7 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 4 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 5 |
| 2023 | 4 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 53 |
| Recruiting | 7 |
| Withdrawn | 4 |
| Suspended | 3 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| New York State Psychiatric Institute | 14 |
| Medical University of South Carolina | 7 |
| University of Colorado, Denver | 6 |
| The Scripps Research Institute | 5 |
| University of California, San Diego | 5 |
| National Institute on Drug Abuse (NIDA) | 4 |
| Brown University | 3 |
| Johns Hopkins University | 3 |
| Yale University | 3 |
| Aelis Farma | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Marijuana Abuse | 69 |
| Pain | 6 |
| Alcoholism | 4 |
| Anxiety Disorders | 4 |
| Substance-Related Disorders | 4 |
| Agnosia | 2 |
| Alzheimer Disease | 2 |
| Attention Deficit Disorder with Hyperactivity | 2 |
| Dyskinesias | 2 |
| Hyperalgesia | 2 |
Trials
Showing 1 to 25 of 69. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.